Home › Bronchiolitis Obliterans › California
Bronchiolitis Obliterans clinical trials in California
3 studies for Bronchiolitis Obliterans are looking for participants at sites in California.
TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients
- University of California San Francisco, San Francisco
RecruitingObservational study
Up to age 24 · All sexes · Updated Jun 22, 2026 · NCT04098445BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
- Stanford University School of Medicine, Stanford
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jun 10, 2026 · NCT05922761A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- City of Hope National Medical Center, Duarte
- Ronald Regan UCLA Medical Center, Los Angeles
- University of California Irvine Health, Orange
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Dec 15, 2025 · NCT06619561From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.